科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02487 科笛-B

休市中 04-30 16:08:11

4.600

-0.090

-1.92%

最高4.840	最低4.580	成交量6.54万
今开4.840	昨收4.690	日振幅5.54%
总市值16.70亿	流通市值16.70亿	总股本3.63亿
成交额30.16万	换手率0.02%	流通股本3.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"科笛-B","latestPrice":4.6,"timestamp":1777536491379,"preClose":4.69,"halted":0,"volume":65400,"delay":0,"changeRate":-0.019189765458422332,"floatShares":363000000,"shares":363000000,"eps":-1.1811283220508964,"marketStatus":"休市中","change":-0.09,"latestTime":"04-30 16:08:11","open":4.84,"high":4.84,"low":4.58,"amount":301552,"amplitude":0.055437,"askPrice":4.72,"askSize":3800,"bidPrice":4.6,"bidSize":55600,"shortable":0,"etf":0,"ttmEps":-1.1891554077347373,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1686499200000,"exchange":"SEHK","adjPreClose":4.69,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.5820576725981597,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02487","defaultTab":"news","newsList":[{"id":"2630030689","title":"FIDELITY CHINA SPECIAL SITUATIONS PLC增持科笛-B(02487)3.06万股 每股作价4.6041港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630030689","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630030689?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:18","pubTimestamp":1777375115,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，4月23日，FIDELITY CHINA SPECIAL SITUATIONS PLC增持科笛-B(02487)3.06万股，每股作价4.6041港元，总金额约为14.09万港元。增持后最新持股数目约为1826.09万股，最新持股比例为5.01%。本交易涉及其他关联方：FIL Limited、Pandanus Associates Inc.、Pandanus Partners L.P.。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","EWH","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157538446","title":"科笛-B（02487）2025年收入达3.36亿元 人员与研发投入聚焦皮肤与毛发创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1157538446","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157538446?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:45","pubTimestamp":1777020329,"startTime":"0","endTime":"0","summary":"科笛-B于本年度实现收入人民币3.36亿元，同比上升20.2%，其中主要产品在毛发疾病与皮肤问题治疗及护理领域带动销售增幅。公司同期毛利约1.96亿元，毛利率提升至58.2%，较上一年度的51.3%明显改善。全年亏损收窄至3.40亿元，同比减少21.6%。管理层将这一结果归因于核心产品的商业化进展、成本控制及运营效率的提升。经营活动现金净流出2.90亿元，较上年同期的4.43亿元进一步收窄，显示公司在费用管控及付款安排方面取得进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科笛-B（02487）2025年收入达3.36亿元 人员与研发投入聚焦皮肤与毛发创新","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174770350","title":"科笛-B授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1174770350","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174770350?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:36","pubTimestamp":1777019794,"startTime":"0","endTime":"0","summary":"科笛-B公告显示，公司董事会已提议授予股份购回一般授权，规模最高可达已发行股份总数的10%，即约36,336,827股。公司将于2026年6月26日召开股东大会，审议并表决该项购回计划。董事会认为，适度购回股份可提升每股价值，并可能提高每股收益，符合公司及股东的整体最佳利益。董事会强调，任何购回安排将以保证上市规定要求的公众持股量为前提。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科笛-B授予董事股份购回授权，规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627481537","title":"港股异动 | 科笛-B(02487)涨超3%  CU-20101（注射用A型肉毒毒素）完成中国III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2627481537","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627481537?lang=zh_cn&edition=full","pubTime":"2026-04-13 13:37","pubTimestamp":1776058657,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科笛-B(02487)涨超3%，截至发稿，涨3.25%，报4.76港元，成交额40.99万港元。消息面上，科笛今日宣布，集团完成CU-20101（注射用A型肉毒毒素）用于改善中度至重度眉间纹的中国III期临床试验。该临床试验旨在评估CU-20101单次及重复注射治疗中重度眉间纹的有效性和安全性。该临床试验以参比制剂保妥适®注射用A型肉毒毒素（“BOTOX®”）作为对照。该临床试验于2025年11月完成所有受试者出组，并于2026年1月完成数据库锁定且取得积极的顶线结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","BK4588","III","02487","BK4134","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627102514","title":"科笛-B(02487)：CU-20101(注射用A型肉毒毒素)用于改善中度至重度眉间纹完成中国III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2627102514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627102514?lang=zh_cn&edition=full","pubTime":"2026-04-13 08:18","pubTimestamp":1776039501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科笛-B 发布公告，本集团完成CU-20101用于改善中度至重度眉间纹的中国III期临床试验。在安全性方面，CU-20101的整体安全性良好，未发生导致提前煺出试验或导致死亡的不良事件，且未发生治疗有关的严重不良事件。CU-20101与BOTOX的安全性评估情况相近，未出现新的安全性信号。CU-20101多次重复注射给药后的有效性及安全性表现与单次用药相似。CU-20101将进一步丰富本集团的皮肤产品矩阵，并有利于与本集团现有产品形成协同效应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4134","III","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141458326","title":"科笛-B更新2026年3月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1141458326","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141458326?lang=zh_cn&edition=full","pubTime":"2026-04-02 21:06","pubTimestamp":1775135198,"startTime":"0","endTime":"0","summary":"科笛集团于2026年4月2日公布截至2026年3月31日的股份变动月报表。公告显示，公司本月无新增发行、回购或注销活动，股本情况保持稳定。公司注册股本为2,500,000,000股普通股，每股面值0.00002美元，总额50,000美元。截至3月31日，已发行股份数量为363,368,277股，库存股份数量为1,362,600股，总计364,730,877股，与上月持平，未发生任何变动。本次月报由执行董事张乐乐签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9589a36a1b64e7c7d7a94166c3b09e9b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198502728","title":"科笛-B2025年收益增长20.2%，亏损较上年同期收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1198502728","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198502728?lang=zh_cn&edition=full","pubTime":"2026-03-24 16:38","pubTimestamp":1774341535,"startTime":"0","endTime":"0","summary":"截至2025年12月31日止年度，科笛-B的收益约为人民币3.36152亿元，此增幅主要来自毛发疾病及护肤产品销售的提升，并且2025年下半年收益较上半年环比增长约307%。同期销售成本约为1.40360亿元，毛利约1.95792亿元，毛利率由上年度的51%上升至约58%，反映高毛利产品销售贡献增加及持续的成本管控。流动比率由2024年的约2.4倍上升至2025年的约2.9倍，短期偿付能力保持稳健。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621057876","title":"科笛-B(02487)发布年度业绩，股东应占亏损3.4亿元 同比减少21.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621057876","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621057876?lang=zh_cn&edition=full","pubTime":"2026-03-24 16:34","pubTimestamp":1774341256,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科笛-B(02487)发布截至2025年12月31日止年度业绩，该集团取得收益人民币3.36亿元(单位下同)，同比增加20.22%;母公司拥有人应占亏损3.4亿元，同比减少21.58%;每股亏损1.03元。本集团的两款主要产品CU-40102(外用非那雄胺喷雾剂)和CU-10201(外用 4%米诺环素泡沫剂)于2025年10月下旬开始商业化。截至2025年12月31日止年度，两款产品收益合计超过1亿元。本集团持续优化经营效率。截至2025年12月31日止年度，销售及分销、研发及行政开支同比减少约1.09亿元。年内亏损同比减少约9400万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02487","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620413631","title":"科笛-B获富达国际增持179.32万股 每股作价5.01港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620413631","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620413631?lang=zh_cn&edition=full","pubTime":"2026-03-17 08:18","pubTimestamp":1773706680,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，3月11日，富达国际增持科笛-B（02487）179.32万股，每股作价5.01港元，总金额约为898.39万港元。增持后最新持股数目约为1979.26万股，最新持股比例为5.43%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-03-17/doc-inhrfwpy2309284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK4539","SG9999011746.SGD","YMM","LU0359202008.SGD","LU0502904849.HKD","IE00BYQNZ168.SGD","LU2242644610.SGD","LU0456842615.SGD","LU0251143458.SGD","LU0327786744.USD","LU0048575426.USD","LU0261950470.USD","BK4022","LU0572944931.SGD","BK4526","LU0359201885.HKD","LU0455707207.USD","LU0359201612.USD","02487","IE00BYTNYN87.SGD","IE00B12V2V27.USD","BK4548","BK4503","BK4232","LU2247934214.USD","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619484884","title":"科笛-B(02487)：CU-40104(外用度他雄胺药剂)新药临床试验申请获得国家药监局临床试验默示许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2619484884","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619484884?lang=zh_cn&edition=full","pubTime":"2026-03-16 08:29","pubTimestamp":1773620964,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科笛-B 发布公告，本集团的CU-40104的新药临床试验申请已获得中华人民共和国国家药品监督管理局临床试验默示许可，适应症为治疗雄激素性脱发。本集团正在研发的外用配方可使度他雄胺直接应用于头皮的作用部位，相比口服度他雄胺，预期外用配方可减少全身性暴露及副作用。本集团相信，CU-40104将进一步丰富本集团的毛发疾病产品矩阵，为本集团已获得国家药监局上市批准的CU-40102起到有价值的补充及协同作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科笛-B(02487)：CU-40104(外用度他雄胺药剂)新药临床试验申请获得国家药监局临床试验默示许可","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619193903","title":"科笛-B盘中异动 股价大跌6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619193903?lang=zh_cn&edition=full","pubTime":"2026-03-13 15:58","pubTimestamp":1773388736,"startTime":"0","endTime":"0","summary":"2026年03月13日临近收盘15时58分，科笛-B股票出现波动，股价大幅下跌6.07%。截至发稿，该股报4.800港元/股，成交量8.58万股，换手率0.02%，振幅5.87%。资金方面，该股资金流入35.9302万港元，流出6.5758万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科笛-B股票所在的生物技术行业中，整体跌幅为1.36%。科笛-B公司简介：科笛集团是一家主要从事皮肤学生物制药业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313155856a6bcfd59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313155856a6bcfd59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618953389","title":"科笛-B盘中异动 下午盘大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618953389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618953389?lang=zh_cn&edition=full","pubTime":"2026-03-10 13:00","pubTimestamp":1773118807,"startTime":"0","endTime":"0","summary":"2026年03月10日下午盘13时00分，科笛-B股票出现异动，股价急速上涨5.10%。截至发稿，该股报4.950港元/股，成交量11.22万股，换手率0.03%，振幅3.61%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科笛-B股票所在的生物技术行业中，整体涨幅为4.55%。其相关个股中，百奥赛图-B、荃信生物-B、加科思-B涨幅较大，振幅较大的相关个股有云康集团、百奥赛图-B、轩竹生物-B，振幅分别为20.88%、18.26%、15.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310130008a6b448e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310130008a6b448e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192172027","title":"科笛-B（02487）2月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1192172027","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192172027?lang=zh_cn&edition=full","pubTime":"2026-03-05 21:06","pubTimestamp":1772715985,"startTime":"0","endTime":"0","summary":"科笛集团于2026年3月5日发布截至2026年2月28日的月度报告。公告显示，公司注册股本维持在2,500,000,000股，面值为每股USD 0.00002，总额USD 50,000，未发生任何增减变动。本月内已发行股份数目维持在363,368,277股，库存股份数目仍为1,362,600股，已发行股份总数合计364,730,877股。报告期内公司并无新增发行、购回、注销或库藏股变动。本月内，未有任何因行使期权产生的新股发行或库存股份转让。公司确认遵守香港联交所《上市规则》及相关法律。上述月报由执行董事张乐乐签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616068581","title":"科笛-B盘中异动 下午盘股价大跌8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616068581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616068581?lang=zh_cn&edition=full","pubTime":"2026-03-04 13:02","pubTimestamp":1772600554,"startTime":"0","endTime":"0","summary":"2026年03月04日下午盘13时02分，科笛-B股票出现异动，股价大幅下挫8.03%。截至发稿，该股报4.240港元/股，成交量3.6万股，换手率0.01%，振幅8.68%。资金方面，该股资金流入4.4512万港元，流出10.8302万港元。科笛-B股票所在的生物技术行业中，整体跌幅为3.89%。其相关个股中，昭衍新药、和誉-B、复宏汉霖涨幅较大，振幅较大的相关个股有帝王国际投资、轩竹生物-B、银诺医药-B，振幅分别为15.60%、13.03%、10.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030413023497a7f54c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030413023497a7f54c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616639691","title":"科笛-B盘中异动 股价大涨6.19%报4.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616639691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616639691?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:53","pubTimestamp":1772502812,"startTime":"0","endTime":"0","summary":"2026年03月03日早盘09时53分，科笛-B股票出现异动，股价急速上涨6.19%。截至发稿，该股报4.800港元/股，成交量5.76万股，换手率0.02%，振幅5.97%。资金方面，该股资金流入18.816万港元，流出4.1972万港元。科笛-B股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，科笛-B、中慧生物-B、翰思艾泰-B涨幅较大，振幅较大的相关个股有和誉-B、银诺医药-B、圣诺医药-B，振幅分别为9.60%、8.32%、7.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603030953329542af46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603030953329542af46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614867123","title":"科笛-B盘中异动 股价大涨7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614867123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614867123?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:39","pubTimestamp":1772156399,"startTime":"0","endTime":"0","summary":"2026年02月27日早盘09时39分，科笛-B股票出现波动，股价大幅拉升7.84%。截至发稿，该股报4.950港元/股，成交量200股，换手率0.00%，振幅0.00%。科笛-B股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，科笛-B、药明合联、创胜集团-B涨幅较大，振幅较大的相关个股有三叶草生物-B、奥星生命科技、康方生物，振幅分别为7.33%、6.58%、6.38%。科笛-B公司简介：科笛集团是一家主要从事皮肤学生物制药业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709395997a7389a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709395997a7389a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614771313","title":"科笛-B盘中异动 早盘快速拉升6.35%报5.190港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614771313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614771313?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:56","pubTimestamp":1771984562,"startTime":"0","endTime":"0","summary":"2026年02月25日早盘09时56分，科笛-B股票出现波动，股价快速拉升6.35%。截至发稿，该股报5.190港元/股，成交量200股，换手率0.00%，振幅0.00%。资金方面，该股资金流入1038港元，流出0港元。科笛-B股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，科笛-B、创胜集团-B、基石药业-B涨幅较大，振幅较大的相关个股有云康集团、帝王国际投资、百奥赛图-B，振幅分别为8.75%、8.55%、6.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022509560297a6ebe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022509560297a6ebe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613748707","title":"科笛-B02月24日主力净流出12.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613748707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613748707?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920947,"startTime":"0","endTime":"0","summary":"02月24日, 科笛-B股价跌1.01%，报收4.88元，成交金额61.1万元，换手率0.03%，振幅14.40%，量比1.51。科笛-B今日主力资金净流出12.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.17%，主力资金累计净流出12.6万元；近20日主力资金累计净流出14.7万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162003a7190be5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162003a7190be5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610605707","title":"每日卖空追踪 | 科笛-B 02月10日卖空量成交1600股，卖空比例为0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610605707?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712233,"startTime":"0","endTime":"0","summary":"科笛-B北京时间02月10日，跌3.58%，卖空量成交1600股，较上一交易日减少33.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163425a492bb14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163425a492bb14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610966894","title":"每日卖空追踪 | 科笛-B 02月09日卖空量成交2400股，卖空比例为0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610966894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610966894?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625831,"startTime":"0","endTime":"0","summary":"科笛-B北京时间02月09日，涨0.19%，卖空量成交2400股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163847a6e550cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163847a6e550cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cutiatx.com","stockEarnings":[{"period":"1week","weight":-0.0171},{"period":"1month","weight":-0.0086},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.3891},{"period":"1year","weight":-0.2333},{"period":"ytd","weight":0.0132}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科笛集团是一家主要从事皮肤学生物制药业务的投资控股公司。该公司致力于皮肤病治疗及护理市场中开发解决方案，涵盖毛发疾病及护理、皮肤疾病及护理、表皮麻醉以及局部脂肪堆积管理。该公司主要从事毛发疾病及护理产品以及若干护肤产品的分销。该公司的主要管线产品包括外用非那雄胺喷雾剂CU-40102、外用4%米诺环素泡沫剂CU-10201、外用新型小分子药剂CU-10101、局部外用利多卡因丁卡因乳膏剂CU-30101和重组突变胶原酶CU-20401。","exchange":"SEHK","name":"科笛-B","nameEN":"CUTIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科笛-B,02487,科笛-B股票,科笛-B股票老虎,科笛-B股票老虎国际,科笛-B行情,科笛-B股票行情,科笛-B股价,科笛-B股市,科笛-B股票价格,科笛-B股票交易,科笛-B股票购买,科笛-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}